Reactive oxygen species may cause oxidative damage in the placenta, yet some mechanisms must exist to reduce or prevent such damage. We investigated whether oxidative injury to placental endothelial cells is inhibited by activation of antioxidant enzymes by paracrine factors secreted by human placental multipotent mesenchymal stromal cells (hPMSC). hPMSCconditioned medium and umbilical endothelial cells were assayed for cytokines and cytokine receptor expression by immunoassay and real-time PCR. Endothelial cell survival was evaluated by MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt] assay and caspase 3 activity assay. tert-Butyl hydroperoxide was used to induce oxidative injury in endothelial cells, with fluorescent microscopy and flow cytometry used to detect intracellular peroxides and cell apoptosis. Western blot, real-time PCR, STAT3 DNA-binding activity assay, and STAT3 siRNA were used to assess endothelial cell antioxidant enzymes. hPMSC-conditioned medium supported endothelial cell survival and reduced endothelial cell intracellular peroxides and apoptosis. hPMSCs expressed the transcripts of the interleukin (IL) 6 cytokine family, including IL6 and leukemia-inhibitory factor. hPMSCconditioned medium activated STAT3 expression in endothelial cells, which was inhibited by neutralizing antibody to interleukin 6 signal transducer (IL6ST) but not to IL6 or leukemiainhibitory factor. STAT3 siRNA or manganese superoxide dismutase (SOD2) siRNA transfected into endothelial cells inhibited the antiapoptotic effect of conditioned medium. SOD2 was significantly upregulated in endothelial cells by conditioned medium via STAT3 activation that, in turn, was inhibited by IL6ST-neutralizing antibody or STAT3 siRNA. Paracrine factors secreted by hPMSCs support endothelial cell survival. STAT3 activation and SOD2 production protect against oxidative stress-induced endothelial cell damage. endothelium, manganese superoxide dismutase, multipotent mesenchymal stromal cells, oxidative stress, placenta, pregnancy
INTRODUCTION
During pregnancy, reactive oxygen species (ROS) are increased [1] , the associated oxidative stress being implicated in the pathophysiology of preeclampsia, intrauterine growth restriction, and diabetes [2] . ROS, including superoxide (ÁO 2 À ), hydrogen peroxide (H 2 O 2 ), and hydroxyl anion (OH À ), are known to cause vascular damage [3, 4] . Without repair, oxidative damage may lead to cell apoptosis. This is countered by antioxidant enzymes that scavenge ROS, including glutathione peroxidase (GPX1), catalase (CAT), and the intracellular superoxide dismutases (SODs), particularly copper/zinc SOD (SOD1) and manganese SOD (SOD2). Although antioxidant effects are generally understood, it remains unclear exactly what mechanisms protect the placenta against oxidative damage.
Mesenchymal stem cells contribute to regeneration and restoration of tissue after stroke, myocardial infarction, or other ischemic diseases [5, 6] . These beneficial effects have been attributed to paracrine factors secreted by the cells [7, 8] , which produce a wide array of soluble growth factors and cytokines, such as vascular endothelial growth factor, basic fibroblast growth factor, hepatocyte growth factor, insulin-like growth factor-1, monocyte hemoattractant protein-1, angiopoietin-1, interleukin (IL) 6, and IL8 [7, [9] [10] [11] . IL6, which has been associated with the pathophysiology of preeclampsia and fetal inflammatory response in particular [12, 13] , has antioxidant properties. For example, IL6 prevented reperfusion injury and apoptosis in rats undergoing fatty liver transplantation [14] . It has also been shown to protect pulmonary alveolar cells from ROS-induced cell death [15] .
Interleukin 6 is expressed and secreted constitutively by mesenchymal stem cells and placental villous cells [16, 17] . It belongs to the IL6 superfamily of cytokines, which includes IL11, leukemia-inhibitory factor (LIF), ciliary neurotrophic factor (CNTF), oncostatin M (OSM), cardiotrophin-1 (CTF1), IL27, cardiotrophin 2/neuropoietin (CTF2), and cardiotropinlike cytokine factor (CLCF) [18] . These cytokines are involved in a variety of biological responses [19] mediated by various signaling cascades. Interleukin 6 signal transducer (IL6ST) is a common subunit of receptor complexes for the IL6 cytokine family [18] . Ligand binding to IL6ST activates the Janus kinase/signal transducer and activator of transcription (STAT) signal transduction pathway, where STAT3 plays a central role in transmitting signals from the membrane to the nucleus [19] . IL6ST-mediated signals have been shown to induce cytoprotective responses in cardiac myocytes and hepatocytes [20, 21] .
In a previous study, we isolated human placental multipotent mesenchymal stromal cells (hPMSCs) [22] . We hypothesized that these cells are instrumental in protecting placental 1 Supported by a grant from the National Science Council (NSC-97-2314-B-195-003-MY3 to C.-P.C.) and Mackay Memorial Hospital (MMH-E 98001 to C.-P.C. endothelial cells from oxidative injury, at least in part through cytokine paracrine effects. In the present study, we prepared hPMSC-conditioned medium (CM) to test for antioxidative and antiapoptotic effects on human umbilical vein endothelial cells subjected to oxidative stress with tert-butyl hydroperoxide (t-BHP) [23] . We then went on to assess the molecular mechanisms that might be involved in such effects, looking particularly at the IL6 cytokine family, because members of that superfamily were present at high concentrations in the CM.
MATERIALS AND METHODS

Cell Cultures
hPMSCs were isolated from clinically normal, human term placentas (37-40 wk of gestation) collected after cesarean section [22] . Tissue was obtained after women gave informed consent, and all experiments were approved by the Institutional Review Board of Mackay Memorial Hospital, Taipei, Taiwan. Briefly, approximately 100 g of tissue from central placental cotyledons were minced, trypsinized (0.25% trypsin-ethylenediaminetetra-acetic acid [EDTA] solution; Invitrogen), treated several times with 10 U/ml of DNase I (SigmaAldrich) in Dulbecco modified Eagle medium (DMEM; Invitrogen) at 378C for 5 min each time, and then filtered through a cell strainer (BD Biosciences). The supernatants were pooled and centrifuged at 3000 rpm for 30 min, and the mononuclear cells in the supernatants were recovered by Percoll density gradient fractionation (1.073 g/ml; Sigma-Aldrich). The cell cultures were maintained in DMEM (Invitrogen) with 10% fetal bovine serum (FBS; Hyclone) at 378C in a humidified atmosphere with 5% CO 2 . hPMSCs were used for experiments at passages 5-8.
Human umbilical vein endothelial cells, collected as previously described [24] , were cultivated using an Endothelial Cell Growth Medium (EGM) Kit with SupplementPack (PromoCell GmbH). The cells at passages 4-6 were used for experiments.
Preparation of CM
The hPMSCs were grown in DMEM with 10% FBS until the cells were 80% confluent. The medium was then removed, and cell layers were washed and incubated with EGM basal medium (PromoCell) supplemented with 1% FBS for 4 days. From this preparation, the CM was collected, centrifuged at 5000 rpm for 10 min, filtered through 0.22-lm filters, and stored at À808C until use. Fresh EGM basal medium containing 1% FBS was used as a control medium (CTL).
Evaluation of Endothelial Cell Survival
Endothelial cells at passages 4-6 were seeded into six-well tissue culture plates (5 3 10 5 cells/well) and cultivated in EGM complete medium (containing SupplementPack with 2% FBS) for 24 h. They were then grown for another 24 h without serum. After washing, the medium was replaced with 1 ml of CM, CTL with 1% FBS, or EGM complete medium containing 2% FBS (positive control). After 3 days of culture in the various media, cell proliferation was assessed by MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt] assay (Cell Titer96 Aqueous; Promega) according to the manufacturer's protocol.
Determination of Cytokines in Medium
Cytokines were detected in the CM and CTL using the FlowMultiplex kit (Bender MedSystems) according to the manufacturer's instructions, which is used to identify the following cytokines: IFNG, IL1B, IL2, IL4, IL5, IL8, IL10, IL12, TNF, and LTA. The detection limit for each cytokine ranged from 4.8 to 43.8 pg/ml. IL6 and LIF were quantified by the Quantikine Human Immunoassay kit (R&D Systems). Each sample was tested in duplicate, and three independent experiments were carried out.
To remove IL6 or LIF from CM, CM was incubated with 3 lg/ml of anti-IL6 monoclonal antibody (R&D Systems) or anti-LIF monoclonal antibody (R&D Systems) for 4 to 6 h at 48C with constant rotation. Then, 20 ll/ml of protein G-agarose beads (GE Healthcare Life Sciences) were added and incubated overnight at 48C with rotation. CM containing agarose beads was centrifuged at 3800 rpm for 3 min, and the supernatant was collected and used immediately. To verify that IL6 or LIF had been removed from the CM, an aliquot of CM stripped of IL6 or LIF through immunoprecipitation was tested for IL6 or LIF concentration by Quantikine Human Immunoassay kit (R&D Systems).
RNA Isolation and Real-Time PCR
The RNA isolation and real-time PCR were performed with SYBR Green PCR Reagents and an ABI PRISM 7700 Sequence Detection System (Applied Biosystems) as previously described [25] . The specific PCR primers used are shown in Supplemental Table S1 (all Supplemental Data are available online at www.biolreprod.org). PCR was initiated after activation of the AmpliTaq Gold enzyme (Applied Biosystems) in the reaction mixture by heating for 10 min at 958C. All genes were amplified by a first step of 15 sec at 958C followed by 1 min at 608C for 40 cycles.
Measurement of Intracellular Peroxides
Measurement of intracellular peroxide production was based on the oxidation of the nonfluorescent dye 2 0 ,7 0 -dichlorofluorescein-diacetate (DCFH-DA; Molecular Probes) to a fluorescent derivative, dichlorofluorescein. Endothelial cells (5 3 10 5 cells/well) were grown in a six-well culture plate for 48 h in either CM or CTL. The medium was then replaced with PBS containing 10 lM DCFH-DA for 30 min. To assess the antioxidative effect, cells were treated with 200 lM t-BHP (Sigma-Aldrich) for 1 h before incubation with DCFH-DA. The fluorescence intensity, measured using flow cytometry and fluorescent microscopy, was compared between cells grown in CM or CTL.
Apoptosis Assay
Endothelial cells (1 3 10 6 cells/dish) were seeded on a 6-cm tissue culture dish with EGM containing 2% FBS for at least 24 h. The cells were incubated with either CM or CTL for 48 h and then treated for 16 h by addition of 200 lM t-BHP. Cells attached to the culture plates were trypsinized using 0.05% trypsin-EDTA at 378C for 3 min. These trypsinized cells as well as those that had been floating in the medium were assessed for viability by incubation with 10 ll of annexin V-fluorescein isothiocyanate and 20 ll of 7-aminoactinomycin (7-AAD; both reagents from BD Pharmingen). The cells were subsequently analyzed by fluorescence-activated cell sorting (FACScan; BD Biosciences). 7-AAD was added to distinguish between early apoptotic
Data analysis was performed with Cell Quest software (BD Biosciences). Ten thousand cells were counted for each sample. hPMSCs were treated in an identical manner to assess their resistance to apoptosis.
Western Blot Analysis
A total protein (25 lg) of endothelial cells was run on Next-Gel (10%; Amresco) and transferred onto an Immobilon polyvinylidene difluoride membrane (Millipore). Immunoblot analysis was conducted using various primary antibodies against specific proteins and appropriate peroxidase-coupled secondary antibodies. The antibodies used are shown in Supplemental Table S2 . The proteins were visualized by using chemiluminescence (Renaissance, DuPont Western Blot Chemiluminescence Reagent; NEN Research). The band densitometry values of interest protein were normalized to the corresponding ACTB (b-actin) bands and were determined semiquantitatively using scanning densitometry (LAS-3000 imaging system; Fujifilm Life Science). The specificity of antibody was verified by the reaction with specific recombinant human protein (positive control) and omission of the primary antibody (negative control).
Nuclear Extract Preparation and STAT3 DNA-Binding Activity Assay
Endothelial cells were pretreated with or without anti-IL6ST antibody (5 lg/ml; R&D Systems) for 1 h, then incubated either with CM or CTL for 72 h in the presence or absence of anti-IL6ST antibody (5 lg/ml). Endothelial cell nuclear extract was prepared using Nuclear Extraction Kit (Chemicon) according to the manufacturer's protocol and stored at À808C until further use. STAT3 DNA-binding activity was evaluated using a Non-Radioactive STAT3 EZ-TFA Transcription Factor Assay kit (Upstate) with a doublestranded biotinylated oligonucleotide containing the STAT consensus sequence according to the manufacturer's manual. Sample luminescence was measured using a microplate luminometer and charged-coupled imaging (LAS-3000 imaging system). STAT3 DNA-binding activity was expressed as relative light units. Each sample was assayed in triplicate.
STAT3 siRNA Transfection
Endothelial cells were transfected with STAT3 siRNA using a STAT3 Validated Stealth RNAi DuoPak (Invitrogen) or SOD2 siRNA (SOD-2 siRNA 906 sc-41655; Santa Cruz Biotechnology). The cells were transiently exposed to either STAT3 siRNA oligo (Invitrogen), SOD2 siRNA oligo (Santa Cruz Biotechnology), or a nonspecific control siRNA-A oligo (Santa Cruz Biotechnology) using Lipofectamine RNAiMAX (Invitrogen) transfection reagent. Briefly, 1 day before transfection, cells were seeded into a 12-well culture plate at 1 3 10 5 cells/well, corresponding to a density of 30-40% at the time of transfection. Cells were transfected with 30 pmol of STAT3 siRNA oligo, SOD2 siRNA oligo, or the nonspecific control siRNA-A oligo in serumfree EGM medium overnight and then switched to CM or CTL medium. After another 72 h, the cells were harvested, and the knockdown effect was assessed by Western blot analysis.
Statistics
The data are presented as the mean 6 SD. At least three independent experiments were carried out for each experiment. Differences were assessed using the independent-samples t-test, paired t-test, or Mann-Whitney U-test when appropriate. A P value of less than 0.05 was considered to be significant.
RESULTS
CM Supports Endothelial Cell Survival In Vitro
To test the capacity of CM to protect endothelial cells from apoptosis in vitro, endothelial cells were plated at near confluence and incubated for 3 days with CM, CTL, or EGM complete medium (as a positive control). No significant change was observed in cell viability when cultured in EGM complete medium for 72 h (Fig. 1A) , but apoptosis was more apparent in endothelial cells cultured in CTL compared with those cultured in CM (Fig. 1A) . On colorimetric MTS assay, cell viability was significantly lower in cells cultured in CTL compared with those cultured in CM (P , 0.001). Furthermore, cells cultured in CTL revealed significantly more caspase 3 (CASP3) activity (cleaved CASP3) than did those cultured in CM (Fig. 1C) . These results suggest that CM supports endothelial survival.
IL6 Family Cytokines Are Expressed in hPMSCs and Their Receptors in Endothelial Cells
Given this ability of CM to support endothelial cell survival, we hypothesized this was a paracrine effect-that is, specific molecules or proteins secreted by hPMSCs could inhibit cell apoptosis. To identify potential mechanisms responsible for this antiapoptotic effect, CM was analyzed by a bead arraybased FlowMultiplex kit and ELISA. High concentrations of IL6 (506.3 6 4.6 pg/ml) and IL8 (347.9 6 14.7 pg/ml) were observed in CM conditioned by hPMSC for 4 days (Fig. 2A) . Additionally, real-time PCR revealed that mRNA transcripts coding for IL6, LIF, CNTF, CTF1, and CLCF were all expressed by hPMSC (Fig. 2B) . Furthermore, endothelial cells expressed mRNA for related receptors, including IL6R, IL11R, LIFR, OSMR, CNTFR, and IL6ST mRNA (Fig. 2C) . IL6 was selected as the primary target for further experiments, because it is secreted constitutively by mesenchymal stromal cells and placental villous cells [16, 17] and has the capacity to inhibit cell apoptosis [26] .
Interleukin 6 signaling involves phosphorylation of the STAT3 transcription factor [19] . We therefore investigated whether STAT3 played a role in the rescue of endothelial cells from apoptosis by CM. CM induced activation of STAT3 in endothelial cells, an effect that, surprisingly, was not inhibited by addition to the CM of IL6 (3 lg/ml) or LIF (3 lg/ml) neutralizing antibodies, either separately or in combination (Fig. 2D) . This result suggests that hPMSC-derived IL6 family cytokines other than IL6 or LIF are involved in the activation of STAT3 transcription factor. The IL6 and LIF levels in the CM after being immunoprecipitated by neutralizing antibodies were nearly undetectable (,5 pg/ml) (Supplemental Fig. S1 ).
CM Induces Activation and Transcriptional Activity of STAT3
The STAT3 transcription factor is a key molecule downstream of IL6ST, the common receptor subunit activated by IL6-related cytokines [19, 27] . To further assess whether CM activated STAT3 through IL6ST, endothelial cells were treated either with CM or CTL for 5, 10, 15, 30, and 60 min. Phosphorylated STAT3 protein was present in endothelial cells as early as 5 min after beginning CM treatment, but the concentration decreased after 60 min in CM (Fig. 3A) . The phosphorylation of STAT3 protein was reduced in endothelial cells with pretreatment and addition of the anti-IL6ST antibody in the CM (Fig. 3A) . On phosphorylation, STAT3 forms a homodimer and translocates into the nucleus, where it activates transcription of target genes. Therefore, we evaluated the DNA-binding activity of STAT3 using nuclear extracts prepared from endothelial cells treated either with CTL or CM. The DNA-binding activity was significantly higher in cells treated with CM compared to those treated with CTL. Similar to the above-mentioned assay of phosphorylated STAT3 protein, STAT3 DNA-binding activity was reduced in endothelial cells in CM to which anti-IL6ST antibody was added (Fig. 3B) .
FIG. 2. Cytokines expressed in CM.
A) Cytokines of IL6 superfamily expressed by hPMSCs determined by FlowMultiplex kit and ELISA, reported as the mean 6 SD (pg/ml). None of them was detected in CTL. B) Quantitative real-time PCR revealed IL6, LIF, CNTF, CTF1, and CLCF mRNAs were expressed in hPMSCs. Upper, threshold cycle (Ct) value of real-time PCR; lower, agarose gel image of real-time PCR products; OSM, oncostatin M. C) Quantitative real-time PCR revealed IL6R (receptor), IL11R, LIFR, OSMR, CNTFR, and IL6ST mRNA were expressed in endothelial cells. Upper, Ct value of real-time PCR; lower, agarose gel image of real-time PCR products. D) CM induced STAT3 activation in endothelial cells, which was not inhibited by anti-IL6 (3 lg/ml) or anti-LIF (3 lg/ml) neutralizing antibodies. The neutralizing antibodies used for IL6 or LIF deprivation in CM by immunoprecipitation were shown in the bottom. EGM, EGM basal medium without serum; neg, negative control; pSTAT3, phosphorylated STAT3.
FIG. 3. CM induced transcriptional activity of STAT3 in endothelial cells.
A) Endothelial cells were treated either with CTL or CM as indicated. Phosphorylated STAT3 protein (pSTAT) was visualized in cell lysates by immunoblotting. Total STAT3 indicates the amount loaded on the gel for each sample. STAT3 activation was reduced in endothelial cells with pretreatment and addition of anti-IL6ST antibody (5 lg/ml) to the medium. B) STAT3 DNA-binding activity was studied using nuclear extracts of endothelial cells treated either with CTL or CM. The CM-induced increase in STAT3 DNA-binding activity was reduced in endothelial cells with pretreatment and addition of anti-IL6ST antibody (5 lg/ml) to the CM. Data from three independent experiments are expressed as mean relative light units (RLU). The lower images were captured by a charge-coupled device camera-coupled imaging system.
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CM Inhibits t-BHP-Induced Intracellular ROS and Protects Endothelial Cells from t-BHP-Induced Apoptosis
Intracellular ROS production appears to be an early and critical event in oxidant-induced cytotoxicity [28] . In endothelial cells incubated with CTL, the addition of 200 lM t-BHP led to a intracellular ROS level remarkably higher than that in cells incubated with CM (Fig. 4A ). This significant difference was further demonstrated by dichlorofluorescein intensity in flow cytometry analysis (Fig. 4 B) , indicating that the ROS level was significantly lower in endothelial cells cultured in CM versus those cultured in CTL (26.6 6 10.6 vs. 53.8 6 2.0, P ¼ 0.008) (Fig. 4B, right) . We then tested whether CM protected endothelial cells from oxidative stress-induced apoptosis. After 48 h of incubation in either CM or CTL, cells were subjected to 200 lM t-BHP treatment for 16 h. Cell apoptosis was assessed using flow cytometry and annexin V staining. The annexin V-positive cell population was significantly lower among CM-treated cells compared with CTLtreated cells (Fig. 4, C and D) . The antiapoptotic effect of CM was inhibited when the endothelial cells were transfected by STAT3 siRNA, as indicated by a significantly higher number of apoptotic cells after STAT3 siRNA transfection compared with nonspecific control siRNA (Fig. 4, C and D) . The number of apoptotic endothelial cells did not differ significantly between those pretreated with CM or those transfected with nonspecific control siRNA before oxidative stress. By contrast, apoptosis occurred in only 2.0% of hPMSCs subjected to the same oxidative stress, indicating that hPMSCs are more resistant to t-BHP-induced oxidative stress than are endothelial cells (Fig. 4, C and D) . Thus, the antiapoptotic effect during oxidative stress of CM on endothelial cells is mediated by STAT3. hPMSCs themselves appear to retain this antiapoptotic property when undergoing oxidative stress.
Increased Antioxidative Enzymes Induced in Endothelial Cells by CM
To further explore the mechanism of protection against oxidative stress by CM, the induction in endothelial cells by CM of four important antioxidant enzymes-SOD1, SOD2, CAT, and GPX1-was examined. The relative antioxidant gene mRNA levels (folds) of endothelial cells were determined by quantitative real-time PCR in three experiments. The mRNA expression of endothelial cell antioxidant genes was standardized against ACTB and then grouped as cells incubated with CM or with CTL. The relative mRNA in cells incubated with CM was normalized against that of cells treated with CTL. After incubating endothelial cells for 48 h, SOD2 mRNA of endothelial cells cultured in CM increased twofold compared with cells cultured in CTL. The expression of SOD1, CAT, and GPX1 mRNA was unaffected (Fig. 5A) . Western blot and densitometric analyses demonstrated the same results at the protein level (Fig. 5B) , indicating that SOD2 is significantly upregulated by CM (P ¼ 0.014), which helps to explain its antioxidative or antiapoptotic effect.
Downregulated STAT3 Expression Reduced SOD2 Protein Expression and Increased t-BHP-Induced Endothelial Cell Apoptosis
We further examined whether SOD2 expression was induced by STAT3 activation in endothelial cells. Treatment with CM resulted in increased STAT3 phosphorylation and SOD2 protein levels. Western blot and densitometric data indicated this effect was abolished in endothelial cells treated with anti-IL6ST antibody (Fig. 6A) . Furthermore, Western blot and densitometric data showed SOD2 expression was reduced when STAT3 expression was knocked down by STAT3 siRNA (Fig. 6B) . When the SOD2 expression was reduced in endothelial cells transfected by SOD2 siRNA, the antiapoptotic effect of CM against t-BHP-induced oxidative stress was decreased compared to the effect in cells transfected by nonspecific control siRNA (Fig. 6C) . The endothelial cell apoptosis assessed by flow cytometry and annexin V staining are shown in Supplemental Figure S2 .
Collectively, our data indicate that paracrine factors secreted into CM containing the IL6 superfamily induce the activation of STAT3 via IL6ST, one effect of which is to enhance SOD2 expression in endothelial cells. This enzyme protects against oxidative stress-induced endothelial cell apoptosis (Fig. 6D) .
DISCUSSION
In the present study, we demonstrated a protective effect of CM against oxidative stress-induced apoptosis in endothelial cells, an effect that was mediated by IL6ST/STAT3. The result of IL6ST/STAT3 activation was upregulation of SOD2, whereas the expression of the SOD1, CAT, and GPX1 genes was unaffected. SOD2 scavenges oxidative stress-induced cellular ROS that may function as signaling intermediaries. One consequence is the inactivation of proapoptotic CASP3. Other mechanisms not assessed by our experiments may also be involved, but we have demonstrated at least one pathway by which hPMSCs protect against oxidative damage-namely, activation of IL6ST/STAT3, leading to an increase in SOD2.
That this antiapoptotic activity was present in the CM indicates paracrine factors produced by the hPMSC are capable of supporting endothelial cell survival; cell-to-cell contact was not required. CM immediately phosphorylated STAT3 and induced SOD2, an effect inhibited by treating endothelial cells with anti-IL6ST antibody. Although we had hypothesized that IL6ST activation was triggered mainly by IL6 or LIF, our antibody neutralization experiments did not bear this out. Treating CM with both anti-IL6 and anti-LIF simultaneously did not abort IL6ST activation. Apparently, other factors in the CM were capable of binding to the receptor as well. This does not mean IL6 and LIF were not involved, a proposition the present study was not designed to assess. However, it does appear that the antioxidant effects of hPMSCs are multifactorial.
Similarly, the present study does not prove that the IL6ST/ STAT3 pathway is the only one by which hPMSCs protect endothelial cells against oxidative injury, but it certainly is involved. STAT3 mediates a broad range of biological processes, including cell survival, proliferation, and immune response [19] . For example, STAT3 activation by carbon monoxide has an antiapoptotic effect in endothelial cells [29] . STAT3 reduces hypoxia/reperfusion-induced cellular damage in the ischemic heart [30, 31] . Overexpression of the constitutively activated form of STAT3 protects against hypoxia/reperfusion-induced apoptosis as well as generation of ROS in hepatocytes [32] . In that study, STAT3 induced upregulation of SOD2, but not of SOD1, with consequent inactivation of CASP3 in hepatocytes [32] . A similar upregulation of SOD1 has been demonstrated in hypoxic cardiomyocytes [30] . The present results are in line with those of all these previous studies. We suggest that induction of SOD2 by IL6ST/STAT3 is crucial to the process by which CM protects endothelial cells against oxidative stress. STAT3 is also associated with other possible antiapoptotic mediators, such as survivin [33] , BCL2 [34] , or BCL2L1 (Bcl-xL) [34] , that enhance endothelial cell survival under conditions of oxidative stress. The present study was not designed to test every possible pathway, but that both anti-IL6ST antibody and STAT3 siRNA transfection effectively blocked increases in SOD2 expression supports our contention that this is a major mechanism in protecting endothelial cells.
The antioxidant effect of CM may well be multifactorial, involving several different cytokines or growth factors. It clearly was a paracrine effect, because the CM itself activated the IL6ST/STAT3 pathway. Given the high concentrations of IL6 and LIF in the CM, we had expected that antibodies to these two cytokines would effectively block activation of the 
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IL6ST receptor. In fact, however, this was not the case. Limited by the presence of antibodies for the other IL6 family member molecules, we could not investigate their expression levels in the CM. We also were not able to determine which of them might also have been key in activating the protective pathway. These findings suggest that the cytokines do not operate in isolation but, rather, interact with other regulatory factors synergistically or by providing redundancy in the system. Sorting out the individual or combined effects of various factors responsible for the full effect of CM is, indeed, a challenge.
The blood vessel wall harbors the main reserve of mesenchymal stem cells in multiple human organs [35] . Mesenchymal stem cells derived from bone marrow, cartilage, and adipose tissue are reported to possess antioxidant ROSscavenging capacity and are resistant to hydrogen peroxideinduced apoptosis or ionizing radiation [36, 37] . The hPMSCs could be perivascular in origin and are more likely derived from stem villi, as demonstrated by Crisan et al. [35] , and may function as cell-secreting paracrine factors for endothelial cell repair and maintenance. The protective effect we have shown is not specific to hPMSCs. For example, in a lethal fulminant hepatic failure mouse model, bone marrow-derived mesenchymal stem cells were able to differentiate into hepatocytes. Importantly, these stem cells were relatively resistant to ROS in vitro and also reduced oxidative stress in stem cell-transplanted mice, effects that were attributed to factors secreted by the mesenchymal stem cells [38] . Although the endothelial cells we used in this model are of umbilical vein origin, which has been shown to be different from microvascular endothelial cells of placenta in phenotypic and physiologic characteristics [39] , stem cells from other origins are expected to protect endothelial cells in different organs from oxidative damage and apoptosis. We observed that hPMSCs were more resistant than endothelial cells to t-BHP-induced apoptosis. Even though we were not able to provide an exhaustive explanation of the paracrine factors expressed by hPMSCs that contribute to scavenging of ROS, these cells clearly are important in the defense against oxidative injury.
In summary, the present study has provided insight regarding at least one mechanism by which hPMSCs may protect the placenta against oxidative stress. ROS are known to damage placental trophoblasts and endothelial cells [40, 41] , producing cell death with features of both necrosis and apoptosis. The distribution of antioxidant enzymes in the placenta varies among different types of cell [2] . However, the present results suggest that protection can be conferred by paracrine factors as well. Might secretion of such factors by hPMSCs be one of the major cytoprotective mechanisms for placental endothelial cells during pregnancy? If that could be conclusively demonstrated in vivo, it would raise the tantalizing possibility that CM might eventually figure in the development of therapy to prevent oxidative stress-related pathology.
